A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according to new research published in The Journal of Nuclear Medicine.

In definitive radiotherapy, reducing the elective dose from 50 Gy to 43 Gy was safe and did not significantly increase the risk for recurrence in electively irradiated lymph nodes among patients with ...

A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients ...

The trial evaluates survival outcomes for recurrent head and neck squamous cell carcinoma post-radiation therapy, comparing ...

For the last 20 years, the standard-of-care adjuvant treatment for resected pathologically defined high-risk resected locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) has been ...

Oral stents have emerged as a valuable adjunct in the radiotherapy of head and neck cancer, allowing clinicians to displace and immobilise non-target tissues, thereby reducing radiation exposure to ...

In patients with early-stage oral cavity carcinoma and a low risk for regional recurrence, omitting elective neck irradiation during postoperative radiotherapy was associated with low rates of ...

A small prospective study from Taiwan showed that olfactory function begins to deteriorate at a radiation therapy dose of 22 Gy in patients with head and neck cancer. Only 17% of patients developed ...

Photobiomodulation therapy significantly reduced severe oral mucositis and PEG tube placements in head and neck cancer patients undergoing radiotherapy. Patient-reported outcomes showed less mouth and ...

An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted from sugarcane and modified in ...

A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according ...